Drug & Supplement Interactions

Cannabidiol (CBD) + Amitriptyline

Brand names of Amitriptyline

  • Elavil
  • Amitid
  • Amitril
  • Endep

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Cannabidiol may increase levels of drugs metabolized by CYP2C19. Of the 6 interaction records for this pair, the most serious is rated moderate.

This also applies to Elavil, Amitid, Amitril and other brand names of amitriptyline.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

CBD can slow how your body clears amitriptyline, so it can build up, with more drowsiness, dry mouth, or dizziness when you stand. Talk with your pharmacist or doctor, since they may want to watch how you feel or check in more closely.

Read his full note1-minute read
Moderate
Probable
6
AOthers: D

Ask a Question About This Combination

Ask in your own words about taking Cannabidiol (CBD) with Amitriptyline. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cannabidiol (CBD) and Amitriptyline Interaction

6 interaction records apply to these two. Each one is explained separately below.

Why Are There 6 Interaction Records?

We file Cannabidiol (CBD)’s interactions under single medicines and under categories of medicines that share an effect. Amitriptyline is named in, or belongs to, 6 of them, so 6 records apply. They can describe the same effect, so they are not 6 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 6

Cannabidiol (CBD) With Cytochrome P450 2C19 (CYP2C19) Substrates

Why this applies to Amitriptyline

  1. The SupplementCannabidiol (CBD)
  2. Interacts With the CategoryCytochrome P450 2C19 (CYP2C19) Substrates
  3. Which IncludesAmitriptyline

We sort drugs into categories. Amitriptyline is in our Cytochrome P450 2C19 (CYP2C19) Substrates category, and Cannabidiol (CBD) interacts with every drug in it, so this interaction applies to Amitriptyline.

Interaction Details Explained

Cannabidiol may increase levels of drugs metabolized by CYP2C19.
Research shows that cannabidiol inhibits CYP2C19. In clinical studies and case reports, cannabidiol use resulted in significant increases in the serum levels of topiramate, methadone, citalopram, omeprazole, and N-desmethylclobazam, the primary active metabolite of clobazam. These chemicals are metabolized by CYP2C19. Concomitant use of cannabidiol with CYP2C19 substrates may increase the risk for adverse effects from these substrates.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
ProbableShown in small studies in people, or in animal studies backed by case reports.
Evidence
Grade ABased on a well-run randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 2C19 (CYP2C19) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist: your body uses an enzyme called CYP2C19 to help break down amitriptyline. CBD slows that enzyme down, and we have good clinical evidence that it does. So when you take the two together, amitriptyline can clear out of your system more slowly and build up to higher levels than usual.

Amitriptyline isn't a prodrug, so higher levels just mean a stronger version of its normal effects. That can show up as extra drowsiness, dry mouth, constipation, blurry vision, dizziness when you stand, or a faster heartbeat. Please don't change anything on your own. Talk with your pharmacist or doctor first. They may want to watch how you feel, adjust your dose, or check in more closely if you start CBD.

Still have a question about this interaction?

Contact Dr. Brian directly

References 9 sources behind this record

  1. Harvey DJ. Absorption, distribution, and biotransformation of the cannabinoids. Marijuana and Medicine. 1999;91-103. DOI
  2. Bornheim LM, Everhart ET, Li J, Correia MA. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 1993;45(6):1323-31. PubMed
  3. Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 2017 Sep;58(9):1586-92. PubMed
  4. Devinsky O, Marsh E, Friedman D, et la. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016 Mar;15(3):270-8.
  5. Geffrey AL, Pollack SF, Bruno PL, Thiele EA. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. 2015 Aug;56(8):1246-51. PubMed
  6. Madden K, Tanco K, Bruera E. Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol. Pediatrics. 2020;e20193256. PubMed
  7. Anderson LL, Doohan PT, Oldfield L, et al. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People. J Clin Psychopharmacol. 2021. PubMed
  8. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  9. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Moderate Interaction 2 of 6

Cannabidiol (CBD) With Cytochrome P450 1A2 (CYP1A2) Substrates

Amitriptyline is also in our Cytochrome P450 1A2 (CYP1A2) Substrates category.

Interaction Details Explained

Cannabidiol may increase levels of drugs metabolized by CYP1A2.
In vitro research shows that cannabidiol inhibits CYP1A2. Furthermore, clinical studies show that cannabidiol may inhibit the metabolism of caffeine, a CYP1A2 substrate. Two pharmacokinetic studies in healthy adults show that taking cannabidiol dosed 640 mg once up to 750 twice daily increases the area under the curve of caffeine. However, results are mixed over whether cannabidiol impacts peak serum levels of caffeine.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
ProbableShown in small studies in people, or in animal studies backed by case reports.
Evidence
Grade ABased on a well-run randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 1A2 (CYP1A2) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the short version: CBD can slow down one of the liver enzymes (CYP1A2) that helps break down amitriptyline. When that pathway gets blocked, more of the drug can hang around in your body. Amitriptyline isn't a prodrug, so higher levels usually mean a stronger effect, not a weaker one.

What might that feel like? The familiar amitriptyline side effects can get more noticeable, things like drowsiness, dry mouth, constipation, blurry vision, dizziness, or a faster heartbeat. This isn't a reason to panic, and it doesn't mean you can't use both. But please loop in your pharmacist or doctor before adding CBD, especially with concentrated supplement doses, so they can watch your dose and how you're feeling.

Still have a question about this interaction?

Contact Dr. Brian directly

References 4 sources behind this record

  1. Yamaori S, Kushihara M, Yamamoto I, Watanabe K. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective potent inhibitors of human CYP1 enzymes. Biochem Pharmacol 2010;79(11):1691-8.
  2. Thai C, Tayo B, Critchley D. A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects. Clin Pharmacol Drug Dev. 2021. PubMed
  3. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  4. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Moderate Interaction 3 of 6

Cannabidiol (CBD) With Cytochrome P450 2C9 (CYP2C9) Substrates

Amitriptyline is also in our Cytochrome P450 2C9 (CYP2C9) Substrates category.

Interaction Details Explained

Cannabidiol may increase levels of drugs metabolized by CYP2C9.
In vitro and animal research shows that cannabidiol inhibits CYP2C9. In human studies, cannabidiol has been associated with an increase in plasma levels of topiramate and losartan, CYP2C9 substrates. Concomitant use of cannabidiol with CYP2C9 substrates may increase the risk for adverse effects from these substrates.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
ProbableShown in small studies in people, or in animal studies backed by case reports.
Evidence
Grade ABased on a well-run randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 2C9 (CYP2C9) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist: your body uses a liver enzyme called CYP2C9 to help clear amitriptyline, and CBD can slow that enzyme down. When the enzyme works slower, more amitriptyline tends to hang around in your system. Since amitriptyline is an active drug (not a prodrug), more of it usually means a stronger effect and a higher chance of side effects.

For amitriptyline, that could show up as extra drowsiness, dry mouth, constipation, dizziness when standing, blurry vision, or a faster heartbeat. We've seen CBD raise levels of other CYP2C9 drugs in real human studies, so this is worth taking seriously. Please don't change anything on your own. Check with your pharmacist or doctor first, since they can watch your dose and how you feel.

Still have a question about this interaction?

Contact Dr. Brian directly

References 6 sources behind this record

  1. Harvey DJ. Absorption, distribution, and biotransformation of the cannabinoids. Marijuana and Medicine. 1999;91-103. DOI
  2. Bornheim LM, Everhart ET, Li J, Correia MA. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 1993;45(6):1323-31. PubMed
  3. Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 2017 Sep;58(9):1586-92. PubMed
  4. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  5. Treyer A, Reinhardt JK, Eigenmann DE, Oufir M, Hamburger M. Phytochemical comparison of medicinal cannabis extracts and study of their CYP-mediated interactions with coumarinic oral anticoagulants. Med Cannabis Cannabinoids. 2023;6(1):21-31. PubMed
  6. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Moderate Interaction 4 of 6

Cannabidiol (CBD) With Cytochrome P450 3A4 (CYP3A4) Substrates

Amitriptyline is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Cannabidiol may increase levels of drugs that are metabolized by CYP3A4.
In vitro and animal research shows that cannabidiol inhibits CYP3A4. In human studies and case reports, cannabidiol has been associated with an increase in plasma levels of the CYP3A4 substrates zonisamide, tacrolimus, everolimus, citalopram, midazolam, and methadone.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
ProbableShown in small studies in people, or in animal studies backed by case reports.
Evidence
Grade ABased on a well-run randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the short version for these two together: your body uses an enzyme called CYP3A4 to help break down amitriptyline. CBD can slow that enzyme down, which means amitriptyline may clear out of your system more slowly and build up to higher levels than usual. Amitriptyline is an active drug (not a prodrug), so higher levels generally mean stronger effects.

In practice, that could show up as more of this drug's typical side effects: drowsiness, dry mouth, constipation, blurry vision, dizziness when standing, or a faster heartbeat. This is a real, well-supported interaction, but it doesn't mean you can never use both. Please don't change anything on your own. Let your pharmacist or doctor know you're considering CBD so they can watch your dose and how you feel.

Still have a question about this interaction?

Contact Dr. Brian directly

References 11 sources behind this record

  1. Yamaori S, Ebisawa J, Okushima Y, et al. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Life Sci 2011;88(15-16):730-6. PubMed
  2. Harvey DJ. Absorption, distribution, and biotransformation of the cannabinoids. Marijuana and Medicine. 1999;91-103. DOI
  3. Bornheim LM, Everhart ET, Li J, Correia MA. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 1993;45(6):1323-31. PubMed
  4. Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 2017 Sep;58(9):1586-92. PubMed
  5. Leino AD, Emoto C, Fukuda T, Privitera M, Vinks AA, Alloway RR. Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus. Am J Transplant. 2019;19(10):2944-2948. PubMed
  6. Wiemer-Kruel A, Stiller B, Bast T. Cannabidiol Interacts Significantly with Everolimus-Report of a Patient with Tuberous Sclerosis Complex. Neuropediatrics. 2019. PubMed
  7. Madden K, Tanco K, Bruera E. Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol. Pediatrics. 2020;e20193256. PubMed
  8. Anderson LL, Doohan PT, Oldfield L, et al. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People. J Clin Psychopharmacol. 2021. PubMed
  9. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  10. Treyer A, Reinhardt JK, Eigenmann DE, Oufir M, Hamburger M. Phytochemical comparison of medicinal cannabis extracts and study of their CYP-mediated interactions with coumarinic oral anticoagulants. Med Cannabis Cannabinoids. 2023;6(1):21-31. PubMed
  11. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Moderate Interaction 5 of 6

Cannabidiol (CBD) With CNS Depressants

Amitriptyline is also in our CNS Depressants category.

Interaction Details Explained

Theoretically, cannabidiol might have additive effects if used with other CNS depressants.
Preliminary clinical research, case reports, and animal studies suggest that high dose cannabidiol has sedative and hypnotic effects. Theoretically, concomitant use of cannabidiol with drugs with sedative and anesthetic properties may cause additive therapeutic and adverse effects.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on what is expected from how the two work, not yet studied.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + CNS Depressants Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the simple version: amitriptyline already makes a lot of people feel drowsy, foggy, or slow, especially when you first start it. CBD, at higher doses, can add its own sedating effect on top of that. So when you pair the two, the worry is mostly about too much sleepiness, more dizziness, trouble concentrating, or feeling unsteady on your feet.

I want to be honest about how strong this concern is. This is a theoretical interaction based on how these things work and some early reports, not solid proof, so it may not bother you at all. Still, go slow, avoid driving until you know how you feel, and check in with your pharmacist or doctor before combining them, especially with concentrated CBD products.

Still have a question about this interaction?

Contact Dr. Brian directly

References 4 sources behind this record

  1. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 1981;21(8-9 Suppl):417S-27S. PubMed
  2. Monti JM. Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology (Berl) 1977;55(3):263-5. PubMed
  3. Pickens JT. Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content. Br J Pharmacol 1981;72(4):649-56.
  4. Perez-Vilar S, Karami S, Long K, Leishear K. Cannabidiol exposures in the United States, National Poison Data System, July 2014-June 2021. Clin Toxicol (Phila) 2022. PubMed
Moderate Interaction 6 of 6

Cannabidiol (CBD) With Cytochrome P450 2D6 (CYP2D6) Substrates

Amitriptyline is also in our Cytochrome P450 2D6 (CYP2D6) Substrates category.

Interaction Details Explained

Theoretically, cannabidiol might increase levels of drugs metabolized by CYP2D6.
In vitro research shows that cannabidiol inhibits CYP2D6. Theoretically, concomitant use of cannabidiol with CYP2D6 substrates might increase the risk for adverse effects from these substrates. However, a clinical crossover trial in healthy adults shows that cannabidiol does not inhibit dextromethorphan, a substrate of CYP2D6.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on what is expected from how the two work, not yet studied.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Cannabidiol (CBD) + Cytochrome P450 2D6 (CYP2D6) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the gist: your body relies on an enzyme called CYP2D6 to help break down amitriptyline. In lab (test tube) studies, CBD can slow that enzyme down. In theory, that could let amitriptyline build up a bit more than usual, which might mean more of its typical side effects, things like drowsiness, dry mouth, constipation, blurry vision, dizziness when standing, or a faster heartbeat.

I want to be honest about the evidence, though. This is mostly theoretical, and a human study using a similar CYP2D6 drug didn't actually show a meaningful problem. So this is worth a conversation, not a panic. Before adding CBD, check in with your pharmacist or doctor so they can watch for any extra grogginess or other effects.

Still have a question about this interaction?

Contact Dr. Brian directly

References 3 sources behind this record

  1. Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 2011;39(11):2049-56. PubMed
  2. Nasrin S, Watson CJW, Perez-Paramo YX, Lazarus P. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions. Drug Metab Dispos 2021;49(12):1070-1080. PubMed
  3. Bansal S, Zamarripa CA, Spindle TR, et al. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther 2023.
Know someone taking this combination? Share

Beyond the Record

What Else We Found About Cannabidiol (CBD) and Amitriptyline

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Cannabidiol (CBD) and Amitriptyline

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Cannabidiol (CBD) or Amitriptyline, not necessarily both.

  1. The pharmacist says

    Ambien CR is not known to cause urine discoloration as a recognized side effect, though the dyes in the tablet could theoretically cause subtle color changes in rare cases. If urine discoloration persists, worsens, or comes with other symptoms like pain or fever, you should contact your doctor to rule out other causes.

    Answered by Dr. Brian Staiger, PharmD · April 2025
  2. The pharmacist says

    Eleuthero may theoretically increase blood levels of some psychiatric medications by affecting how your liver breaks them down, based mainly on lab and animal studies rather than proven human effects. Most research suggests that even if eleuthero does affect these liver enzymes, the change is unlikely to be clinically significant in most people. Always talk to your doctor or pharmacist about your specific psychiatric medications before taking eleuthero to get personalized guidance about your individual situation.

    Answered by Dr. Brian Staiger, PharmD · July 2023
  3. The pharmacist says

    Both amitriptyple and passionflower can cause drowsiness, and taking them together may increase this sedative effect.

    Answered by Dr. Brian Staiger, PharmD · April 2023
Published Research

Studies That Mention Both Cannabidiol (CBD) and Amitriptyline

lists 17 records naming both. These are the most relevant that discuss the two together. Mentioning both is not a finding about taking them together, so treat them as a starting point.

  1. Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors. The Journal of Pharmacology and Experimental Therapeutics · 2024 · Lab or animal study · PMID 38129125
  2. Low-dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug-drug interaction study. British Journal of Clinical Pharmacology · 2026 · In people · PMID 41398552

Other Records That Name Both

These name both, but never in the same sentence or only in a lab method, so they may be about something else.

  1. [Not Available]. Gastroenterologia Y Hepatologia · 2026 · Review · PMID 42843625
  2. Nonopioid drugs for pain. The Medical Letter on Drugs and Therapeutics · 2022 · In people · PMID 35231019
  3. Drugs for anxiety disorders. The Medical Letter on Drugs and Therapeutics · 2019 · Review · In people · PMID 31386647
  4. Diabetic Peripheral Neuropathy: Prevention and Treatment. American Family Physician · 2024 · In people · PMID 38574212
  5. In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs. Purinergic Signalling · 2023 · Lab or animal study · PMID 36781825
  6. Top 20 Research Studies of 2022 for Primary Care Physicians. American Family Physician · 2023 · In people · PMID 37054418

See all 17 on PubMed

Reports to the FDA

492 reports to the FDA list both Cannabidiol (CBD) and Amitriptyline.

What this means: someone took both, then had a health problem. It does not show either one caused it. In all 5 newest reports, another medicine was the suspect. These two were 2 of the 6 to 43 products each person was taking.

  • 492Reports that list both
  • 458Marked serious by the reporter
  • 353From doctors, pharmacists and other health professionals
  • 134From patients and other consumers
The 5 Newest Reports
Who sent them, what happened and which medicine was suspected
ReceivedReported byWhat happenedMedicine suspectedCannabidiol (CBD)Amitriptyline
June 2026Report 26903663 A physician Persistent genital arousal disorder, Orgasm abnormal, Genital painSerious: hospital stay, medically important Duloxetine8 products listed Also taking Also taking
June 2026Report 26872295 A consumer Upper limb fracture, FallSerious: hospital stay Dupixent43 products listed Also taking Also taking
June 2026Report 26833763 A consumer Migraine, Memory problems (cognitive disorder), Memory problems (memory impairment)Serious: disability Aimovig6 products listed Also taking Also taking
May 2026Report 26811808 A physician Paraplegia, Shrinking lung syndrome, Wheezing (asthma)Serious: medically important Dexamethasone Sodium Phosphate, Piroxicam and 2 more22 products listed Also taking Also taking
May 2026Report 26730281 A consumer Aspiration, Perforated ulcer, Bleeding in the gut (hematemesis)Serious: life-threatening, hospital stay, medically important Adalimumab-aaty19 products listed Also taking Also taking
Problems Named Most Often

Across all 492 reports, whatever was suspected. Not what this pair causes.

  • Shortness of breath (dyspnea)107
  • Rash106
  • Joint pain (arthralgia)99
  • Drug ineffective95
  • Nausea90
  • Pain84
How we searched

PubMed: searched October 2026, and again every few months. PubMed lists research but does not grade it; the rating above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read October 2026. Matched by name, so a report may name a product that contains Cannabidiol (CBD). The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Cannabidiol (CBD) Also Interacts With Other Medications

Besides Amitriptyline, Cannabidiol (CBD) has 1,052 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Cannabidiol (CBD)

Covers the 2,830 medications we’ve checked against Cannabidiol (CBD). Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Amitriptyline

Take other supplements too? 300 supplements have a documented interaction with Amitriptyline, each explained on its page.

By severity: 17 major, 231 moderate and 52 minor.

The Most Serious There Right Now:

Open the Amitriptyline interaction pageEvery supplement checked against Amitriptyline, ranked by severity

Get to Know Each One

About Cannabidiol (CBD) and Amitriptyline

Supplement

About Cannabidiol (CBD)

CBD is a compound from the cannabis (hemp) plant that does not cause a 'high.' It has strong evidence only for certain rare seizure disorders (as a prescription drug), while most other popular uses are still backed by limited or early research. Product quality varies a lot, so talk with your pharmacist or doctor before using it, especially if you take other medicines.

Full Cannabidiol (CBD) guide: uses, dosage, safety and every interaction
Medication

About Amitriptyline

Brand names: Elavil, Amitid, Amitril, Endep

Amitriptyline tablets are used to relieve the symptoms of depression. This use is the same across the amitriptyline tablet products described here.

Amitriptyline: uses, dosage and side effects Amitriptyline: interactions with other drugs Taking more than these two? Check Cannabidiol (CBD) and Amitriptyline with everything else you take Amitriptyline Hydrochloride NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Cannabidiol (CBD) and Amitriptyline

Other drugs in the category this interaction applies to, and other supplements people check with Amitriptyline.

Moderate

Also in Our CNS Depressants Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

231 more in this category are on the Cannabidiol (CBD) interactions list.

Moderate

Also in Our Cytochrome P450 2D6 (CYP2D6) Substrates Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

176 more in this category are on the Cannabidiol (CBD) interactions list.

Moderate

Also in Our Cytochrome P450 2C19 (CYP2C19) Substrates Category

Cannabidiol (CBD) interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

55 more in this category are on the Cannabidiol (CBD) interactions list.

Other Supplements With Amitriptyline

The most serious documented interactions with Amitriptyline first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Cannabidiol (CBD)

Browse every other medication we’ve checked against Cannabidiol (CBD) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1,052Moderate
0Minor
1,777No known interaction
Moderate

Moderate: 1,052 interactions

Showing 60 of 1,052 moderate interactions — see all 1,052 on the Cannabidiol (CBD) page.

No Interaction 1,777 drugs checked — show the list

We also checked Cannabidiol (CBD) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 1,777 medications checked with no known interaction, the most looked-up first — see the full Cannabidiol (CBD) list.

How Much People Look This Up

Where Cannabidiol (CBD) and Amitriptyline Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabidiol (CBD)
Top 25%

#353 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Amitriptyline
Top 5%

#35 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cannabidiol (CBD) and Amitriptyline Together: Common Questions

Can you take Cannabidiol (CBD) with Amitriptyline?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Cannabidiol (CBD) with Elavil?
Elavil is a brand name of amitriptyline, and so are Amitid and Amitril, so the answer is the same as for amitriptyline. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Elavil too.
Why are there 6 interaction records for Cannabidiol (CBD) and Amitriptyline?
We file interactions under single medicines and under categories of medicines that share an effect. Amitriptyline is named in, or belongs to, 6 of the categories we list for Cannabidiol (CBD), so 6 records apply. They can describe the same effect, so they are not 6 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Cannabidiol (CBD) and Amitriptyline interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.
Has Cannabidiol (CBD) been studied with Amitriptyline?
We searched PubMed, the National Library of Medicine's index of medical research, in October 2026. It lists 17 records that name both Cannabidiol (CBD) and Amitriptyline; the most relevant that discuss the two together are listed on this page with links to PubMed. A study that discusses both is not a finding about taking them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Cannabidiol (CBD) and Amitriptyline?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.